All generics articles – Page 3
-
Business
Generics giants jostle over pain drug
Mylan and Actavis contest Teva’s generic celecoxib exclusivity
-
Opinion
It's life, but not as we know it
A living cell that uses artificial bases in its DNA heralds a profound development for chemistry, says Mark Peplow
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business
Sun set on Ranbaxy rescue
Acquiring beleaguered firm will create India’s biggest pharmaceutical company
-
Business
Lilly wins cancer drug patent dispute
Alimta patent will last until 2022 after US court rules in Lilly’s favour
-
Business
Megamerger brings Actavis into R&D race
$25bn Forest Labs takeover will see generics giant take on patented products
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
Business
Chinese police seize £222m of fake drugs
1300 people are arrested in a nationwide crackdown on counterfeit medicines
-
Feature
Generic problems
The Indian pharmaceutical industry has been hit by recent problems. Angeli Mehta investigates
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
Business
Aspen in $1 billion deal with Merck & Co
South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
Business
$500m fine over generics fraud for Ranbaxy
Company has pleaded guilty to fabricating data and producing substandard drugs
-
Business
Buy Viagra online - direct from the manufacturer
Pfizer launches website for mail order erectile dysfunction drug prescriptions
-
Business
Ireland picks preferred drugs
Using the cheapest of equivalent options could save healthcare providers millions
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page